Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)450.37
  • Today's Change-0.86 / -0.19%
  • Shares traded1.51m
  • 1 Year change+26.94%
  • Beta0.3661
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue9,8698,9317,574
OPERATING EXPENSES
Cost of revenue total1,2621,080904
Selling, general and admin. expenses, total1,137945840
Depreciation/amortization------
Unusual expense(income)527129--
Other operating expenses, total(52)(58)(3.1)
Total operating expense6,0374,6234,792
Operating income3,8324,3072,782
Other, net(15)(16)(12)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes4,3804,2322,730
Provision for income taxes760910388
Net income after taxes3,6203,3222,342
Minority interest------
Net income before extra. Items3,6203,3222,342
Total extraordinary items------
Net income3,6203,3222,342
Inc.avail. to common excl. extra. Items3,6203,3222,342
Inc.avail. to common incl. extra. Items3,6203,3222,342
EPS RECONCILIATION
Basic/primary weighted average shares258256258
Basic/primary eps excl. extra items14139.09
Basic/primary eps incl. extra items14139.09
Dilution adjustment------
Diluted weighted average shares261259260
Diluted eps excl. extra items14139.01
Diluted eps incl. extra items14139.01
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental445562
SUPPLEMENTAL INCOME
Depreciation, supplemental168148126
Total special items527129--
NORMALISED INCOME
Normalized income before taxes4,9074,3612,730
Effect of special items on income taxes02.80--
Income tax excluding impact of special items760913388
Normalized income after tax4,1473,4482,342
Normalized income avail. to common4,1473,4482,342
Basic normalized EPS16139.09
Diluted normalized EPS16139.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.